{
  "url": "https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-2016/schedule-3/paragraph-8",
  "json_url": "https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-2016/schedule-3/paragraph-8.json",
  "legislation": "uksi/2016/190",
  "legislation_title": "The Medicines (Products for Human Use) (Fees) Regulations 2016",
  "legislation_url": "https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-2016",
  "path": "schedule/3/paragraph/8",
  "kind": "paragraph",
  "number": "8",
  "heading": "Broker's registrations",
  "text": "(1) Except in the case of an inspection where sub–paragraph (2) applies, the inspection fee payable in connection with the grant, variation or review of a broker's registration is—\n(a) £3,241 if the time taken to make the inspection is not more than 1 day; and\n(b) if the time taken is 1 day or more, £3,241 for the first day and £1,621 for every subsequent period of 3 hours and 30 minutes or less taken to make the inspection.\n(2) This paragraph applies where an application or variation of a broker's registration is considered under paragraph 10 but it is necessary to carry out a site inspection before the registration is granted or varied.\n(3) If sub-paragraph (2) applies, a fee of £780 is payable in addition to any fee under paragraph 10.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Sum in Sch. 3 para. 8(1)(a) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 28(6)(a)(i)"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Sum in Sch. 3 para. 8(1)(b) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 28(6)(a)(i)"
    },
    {
      "type": "F",
      "label": "F3",
      "text": "Sum in Sch. 3 para. 8(1)(b) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 28(6)(a)(ii)"
    },
    {
      "type": "F",
      "label": "F4",
      "text": "Sum in Sch. 3 para. 8(3) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 28(6)(b)"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2016/190/schedule/3/paragraph/8",
    "retrieved_at": "2026-10-28T23:27:13.215121+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}